Trial Profile
A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study of Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Alcohol withdrawal
- Focus Biomarker; Therapeutic Use
- 02 Nov 2015 New trial record